{"name":"MEI Pharma","slug":"mei-pharma","ticker":"MEIP","exchange":"NASDAQ","domain":"meipharma.com","description":"MEI Pharma is a biopharmaceutical company focused on developing innovative therapies for patients with cancer. The company's pipeline includes several oncology candidates, with a focus on targeting key signaling pathways. MEI Pharma has a strong presence in the oncology biotech sector, with a growing portfolio of clinical-stage assets. The company's key products include vorasidenib, a potent and selective inhibitor of IDH1 mutations.","hq":"San Diego, CA","founded":0,"employees":"","ceo":"David Urso","sector":"Oncology Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$95M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":3923000,"netIncome":-15945000,"cash":18011000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"Vorasidenib patent cliff ($0.0B at risk)","drug":"Vorasidenib","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"PWT-143","genericName":"PWT-143","slug":"pwt-143","indication":"Other","status":"phase_1"},{"name":"phenoxodiol","genericName":"phenoxodiol","slug":"phenoxodiol","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"PWT-143","genericName":"PWT-143","slug":"pwt-143","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"phenoxodiol","genericName":"phenoxodiol","slug":"phenoxodiol","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"MEI Pharma Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"MEI Pharma reported its financial results for the fourth quarter and full year 2023, with a net loss of $14.4 million for the year.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"MEI Pharma Announces Collaboration with National Cancer Institute to Develop Novel Cancer Therapies","summary":"MEI Pharma entered into a collaboration with the National Cancer Institute to develop novel cancer therapies targeting key signaling pathways.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-02-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-17","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-02-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-12-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-12-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPMGpSUW1UUnBGS0VZbU1LMGV6eC12RlJPMWlCbVdjVHp4UWtISDdQSkVwbFFBY0lxNWpqOVE0Sjd5WWZNeUJuVktyN0d4RUV1dkpTTVdFbkpZQnNOZlR0MlpvbW1WSmc5cVowQVhKN3dqSkNqSDFscnBERTVDZG1ieXpDandpR21FMzFsRGxrenl3eDJ1T2NMZkhMMVNWb1hpN0VHclJOYUVTLWZoeGhHM280MzNFbjUyMTJhREJXdVZKbTlq?oc=5","date":"2025-09-11","type":"pipeline","source":"The Globe and Mail","summary":"MEI Pharma Rebrands to Lite Strategy, Inc. - The Globe and Mail","headline":"MEI Pharma Rebrands to Lite Strategy, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQR0VZdDFxVGVxRFN1cldvWmVEYVZ1TlJDMXZOYmdfTGJlbkh1MG96Tmp2TjZ1RnVBeVpOMnF6UDNZeG5fSVZpM0htcUplVjQwQVBlaV80MHVCczlDTnl6aGFHOE5EOWRVbVNGMGxKaHZTb0g4akZiZ3VRUE95dDZvX09FX2gxUXp1WkJ0OVJsZGdPd2JsOU5mcXNSNkFVNEpHamJPY0NhbEhyRWJ4V0Zoa3NDNjJyUUtVcEFhckRQTWJCRUNyS0JsXzlNbzJWdw?oc=5","date":"2025-09-10","type":"pipeline","source":"Business Wire","summary":"MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’ - Business Wire","headline":"MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNamJNLUtBMW1VWEg5TE5OT3FBUzktcmRkOF9yMWJ1SmJZbUE1NHdVbUpBVDY4UkJGNmptRmtBMmt6VzV1MXZsN0NwT21jUGxMbmFKMTRHRVVEWW82MG1vNXVBS2hsXzlUU0FuMjFDRkNLWnpyRUFSclF3NnU5WktsbGJIc19XUC1BcDFPUlpLam1mYWRQd2VORl8tc2JjRXM?oc=5","date":"2025-09-10","type":"pipeline","source":"Fierce Biotech","summary":"MEI Pharma leaves biotech woes behind to rebrand as crypto company - Fierce Biotech","headline":"MEI Pharma leaves biotech woes behind to rebrand as crypto company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1LYS1XaUJYNTJaSmhGcjJzZW1yc3RDYmxtWURBOF9OVkhUTTZJN0RodGdpWkxiVXpFdnNNOW52MU0xY0ZTeG9MUGFyT0hpRmZPZXN2dEhrcEpXM1BWWXlB?oc=5","date":"2025-09-10","type":"pipeline","source":"ChartMill","summary":"MEIP Stock Price, Quote & Chart | MEI PHARMA INC (NASDAQ:MEIP) - ChartMill","headline":"MEIP Stock Price, Quote & Chart | MEI PHARMA INC (NASDAQ:MEIP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNaWpWUUlEcWVVSHp0MGZncnZ6SFFwNFN2NjBFaFZXME9OcW1GTU9BVDRLbGtISDhRanFaSjBxTTlHdGI4YV9tZDNkWGtIZGpBckJCOHpkM2tyaWJQWGFEV1dfcFNjcXpCZmpWMFVWeWE4UUFYWTRSc1pEOTZaQUtHckFPclNlMDV6NXI4VS16OTFGUHc?oc=5","date":"2025-08-05","type":"deal","source":"The Block","summary":"MEI Pharma buys $100 million of Litecoin as treasury asset, with Charlie Lee and GSR as lead investors - The Block","headline":"MEI Pharma buys $100 million of Litecoin as treasury asset, with Charlie Lee and GSR as lead investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQYnRBbTluTkxhQVNQdTR6OU4tai1ybk96U1FyUFZKVmF4SmVOcXIwY0xVSXFiWWRWTlRSaDVDNXNXaEpjVnh2QUw2cWJ4YXM0UGV5bldsVHhaUDhfSTFDSWctR3dzZFkxd0hTVEhwcDJwQmo3bk5wMUFFVmluTmxzUjV3?oc=5","date":"2025-08-05","type":"pipeline","source":"Yahoo Finance","summary":"MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset - Yahoo Finance","headline":"MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPc1BaOW9OeFh4QktvTkhrRHdobUJfSnROQ1RnTTRDaGJSWHUxcXBOYmNoNWZickEtMC1NcGpWZmFYUFNzY2daaDNHQ1ZObWFiWTViaEtFbDFYOGVZQmZJeFRkcUljNTFMM29QWDZTSGs0OXlyTXl5MTdQMnF0clhqOUxaRWlGMjBvZFBRSmh5eXRXZURGTGQxT0ZneGZDOVUyWkRNSFFaLU92NFo4Y0NkRHZuSjEtWXFLOHAyT2JPdGM?oc=5","date":"2025-07-22","type":"deal","source":"Investing.com","summary":"MEI Pharma adopts Litecoin as treasury reserve in $100 million deal - Investing.com","headline":"MEI Pharma adopts Litecoin as treasury reserve in $100 million deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxQazJoamlhdmFnWlJ3VjhPMmphWTVSR2l1cVRKLVBueldUbUVIYVdRa0lTcldMU3hTaWY5ekt0V2c2cDZ6OWNfeXNNLTVvby1XWFFMWWhQcldZOWZvZl9tZGUzMGRXcWhoWGowVjBwVzJhSGg1SXBPZE1UM2t3NjJGbXdPSmhzbUNSbDVsX0dJbU1sVW9zOUcyVWpKSENtc0lnS094T1JSR01NVTYzMlJzXzRxUjJ4aldFSUJ1cmcxZE5ld1cxNHJ6UUJEQldUc3RzWHJiOVQwZUZIem5LbUZsY2EtTHdyaFJnX21HUFd6TW9wY2VsdVI1aFZOaFVyWWdfdVhWRGx4U014TVF4dVR4TnVyb2dnaXpBMHFKUTc1QVEwV01FY3BLTHgzOFlQeE5pUWJCX1dDWWhEdW1xeTdtak05WDBTQ1lZXzFIRkZ2c0FlQQ?oc=5","date":"2025-07-22","type":"pipeline","source":"Business Wire","summary":"MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire","headline":"MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First an","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1fVFNBZUZua2R3bXNYbnkwRzRsWWFKUFlaQjd6bldYWncwVVlqOVJjZkpjQU1QN0Y4WW9NbXpMMy1HV0hXaTZxaVRySzB2SG9YUU9JWnllSERCaU01ZVB3LWVnbw?oc=5","date":"2025-07-21","type":"pipeline","source":"Binance","summary":"LTC Hits Wall Street Stage: MEI Pharma's 'Litecoin Treasury' Surges Over 80% - Binance","headline":"LTC Hits Wall Street Stage: MEI Pharma's 'Litecoin Treasury' Surges Over 80%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQNW0tUnc4UHh1T0lhOWktNHRjVm9qNWwyNUNRcW1GMkE5TnQ3VXpzYTlaY3pyQ1UxVG44Vl9FRGR2NWpyeERiQ2FJX2VBbDZsSkx6dml6OXYxU2k4aWJOWHlFSFlJMDhRWTVlamtFcEZBanZFb0tVbnFjYmlSNUhWYg?oc=5","date":"2025-07-19","type":"pipeline","source":"Yahoo Finance","summary":"MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange - Yahoo Finance","headline":"MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange","sentiment":"neutral"}],"patents":[{"drugName":"Vorasidenib","drugSlug":"vorasidenib","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":0}],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Clovis Oncology","Aurora Biopharma","Kura Oncology"],"therapeuticFocus":["Oncology"],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2025-06-30","revenueHistory":[{"value":0,"period":"2025-06-30"},{"value":65297000,"period":"2024-06-30"},{"value":48816000,"period":"2023-06-30"},{"value":40697000,"period":"2022-06-30"},{"value":25535000,"period":"2021-06-30"},{"value":28913000,"period":"2020-06-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":3923000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-15945000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":18011000,"cashHistory":[],"totalAssets":18285000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}